鄭光宏 教授兼生醫所所長
專長領域:胰臟癌研究、癌症幹細胞研究、幹細胞生物學、幹細胞訊息傳遞
聯絡電話:07-5252000分機:7107、7114
E-mail:khcheng@faculty.nsysu.edu.tw
1992 | 高雄醫學院醫技系學士 | |
1995 | 中興大學分子生物研究所碩士 | |
2003 | 美國波士頓大學醫學院病理博士 | |
2004 - 2005 | 美國波士頓大學附設醫學院博士後研究員 | |
2005 - 2007 | 美國哈佛醫學院附設麻州總醫院癌症中心博士後研究員 | |
2007 - 2008 | 美國哈佛醫學院附設柏雷根婦女醫院博士後研究員 | |
2008 - 2014 | 中山大學生物醫學所助理教授 | |
2014- 2019 | 中山大學生物醫學所副教授 | |
2019- | 中山大學生物醫學所教授 | |
1.Pancreatic cancer research | ||
2.Cancer biology | ||
3.Cancer stem cell research | ||
4.Stem cell biology | ||
5.Stem cell signal transduction | ||
Method of determining gene expression-Targeted Expressed Gene Display- application pending U.S.S.N 60/457,472:BU03-16, Boston University. USA | ||
A novel loss of heterozygoisity (LOH) analysis method -Dilution End point LOH Analysis (DELA)- application pending, Boston University, USA | ||
新式專利 檢測女性癌症之裝置- 台灣 1479-NCSU-TW 發明人 鄭光宏 2013/11 至 2016/11 | ||
台灣專利 苦楝花粗粹液保肝及/或治療癌症的功效 台灣專利第101107069號 發明人 鄭光宏 翁靖傑 蘇惠庭 2014/12 至 2017/12 | ||
台灣專利 居家使用簡易型糞便早期篩檢胰臟癌的檢測模組 台灣專利申請中 發明人 鄭光宏 郭子雷 翁靖傑 郭功楷 | ||
2008 Ruth L. Kirschstein National Research Service Award Fellowship (2nd year), USA | ||
2007 Program of Excellence Award, the Ovarian Cancer Research Fund, Inc., USA | ||
2007 Ruth L. Kirschstein National Research Service Award Fellowship, USA | ||
2004 10th Russek Student Achievement Awards (Honorable Mention), Boston University School of Medicine, USA | ||
2003 Best Poster Award, First Annual Retreat, Department of Genetics and Genomics, Boston University School of Medicine, USA | ||
出版年月 | 著作類別 | 著作名稱 | 作者 | 收錄出處 |
---|---|---|---|---|
2020 | 期刊論文 | Inhibition of b-catenin activity abolishes LKB1 loss driven pancreatic cystadenoma in mice. | Hsieh MJ, Weng CC, Lin YC, Wu CC, Chen LZ,* and KH Cheng 本人為共同通訊作者 | Int J Mol Sci. |
2020 | 期刊論文 | Inactivation of APC induces CD34 upregulation to promote epithelial-mesenchymal transition and cancer stem cell traits in pancreatic cancer | Hsieh MJ, Chiu TJ, Lin YC, Weng CC, Weng YT, Hsiao CC,* and KH Cheng 本人為通訊作者 | Int J Mol Sci. |
2019 | 期刊論文 | The use of genetically engineered mouse models for studying the function of mutated driver genes in pancreatic cancer. | Weng CC, Lin YC, Cheng KH. 本人為通訊作者 | J Clin Med. |
2019 | 期刊論文 | Low-energy extracorporeal shock wave therapy ameliorates kidney function in diabetic nephropathy. | Hsiao CC, Huang WH, Cheng KH, Lee CT. | Oxid Med Cell Longev |
2019 | 期刊論文 | Deciphering The Potential Role of Hox Genes in Pancreatic Cancer. | Kuo TL, Cheng KH, Chen LT, Hung WC. | Cancers (Basel). |
2019 | 期刊論文 | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven Development of pancreatic cancer. | Weng CC, Hsieh MJ, Wu CC, Lin YC, Chen LZ, Hung WC, Cheng KH. 本人為通訊作者 | Mol Cancer. |
2019 | 期刊論文 | β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer. | Kuo TL, Cheng KH, Shan YS, Chen LT, Hung WC. | Theranostics. |
2019 | 期刊論文 | MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death. | Wang YY, Chen YK, Hu CS, Xiao LY, Huang WL, Chi TC, Cheng KH, Wang YM, Yuan SF. | Oral Dis. |
2019 | 期刊論文 | Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis. | Weng CC, Ding PY, Liu YH, Hawse JR, Subramaniam M, Wu CC, Lin YC, Chen CY, Hung WC, Cheng KH. 本人為共同通訊作者 | Oncogene. |
2018-12 | 期刊論文 | K-ras and p53 promotes PDGF/Src-dependent growth and metastasis in pancreatic cancer | T-L. Kuo , K-H. Cheng , Y-S. Shan , L-T. Chen , W-C. Hung | Theranostics |
2018-12 | 期刊論文 | Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis. | Weng C-C*, P-Y Ding*, Y-H Liu, John R. Hawse, Malayannan Subramaniam, C-C Wu, Y-C Lin, C-Y Chen, W-C Hung, K-H Cheng | Oncogene |
2017-09 | 期刊論文 | KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model. | C-C., Weng, H-S., Vincent, Chang, SA. Johnsen, M., Subramaniam, Winston C.Y. Yu, C-Y., Chen, W-C., Hung, L.Z., Chen and Cheng, KH | Oncogene |
2017-04 | 期刊論文 | KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice. | Tang FH, Hsieh TH, Hsu CY, Lin HY, Long CY, Cheng KH, Tsai EM. | Int J Cancer. |
2017-04 | 期刊論文 | WDR4-driven PML destruction fosters immunosuppressive and pro-metastatic lung tumor microenvironment. | Wang YT, Jocelyn Chen, C-W Chang, Jayu Jen, T-Y Huang, C-M Chen, Roger Shen, S-Y Liang, I-C Cheng, S-C Yang, W-W Lai, K-H Cheng, T-S Hsieh, M-Z Lai, H-C Cheng, Y-C Wang, R-H Chen | J Clin Invest. |
2016-05 | 期刊論文 | Suppression of IL8-Src Signaling Axis by 17β-Estradiol Inhibits Human Mesenchymal Stem Cells-Mediated Gastric Cancer Invasion. | Liu, C-J., Kuo, F-C., Wang, C-L., Kuo, C-H., Sophie S.W. Wang, Chen, C-Y., Hunag, Y-B., Cheng, K-H., Yokoyama, K., Chen, C-L., Ku, C-Y., Wu, D-C | J. Cell. Mol. Med |
2016-04 | 期刊論文 | APC haploinsufficiency coupled with P53 loss is sufficient to induce mucinous cystic neoplasms and invasive pancreatic carcinoma in mice | Tzu-Lei Kuo, Ching-Chieh Weng, Kung-Kai Kuo, Chiao-Yun Chen, Deng-Chyang Wu, Wen-Chun Hung, Kuang- Hung Cheng | Oncogene |
2016-03 | 期刊論文 | Pancreatic tumor progression associated with CD133 overexpression: involvement of increased TERT expression and EGFR-dependent Akt Activation | Ching-Chieh Weng*, Kung-Kai Kuo*, Huei-Ting Su, Pi-Jung Hsiao, Yu-Wen Chen, Deng-Chyang Wu, Wen-Chun Hung, Kuang- Hung Cheng | Pancreas |
2016-01 | 期刊論文 | Quantitative Proteomic Analysis of Differentially Expressed Profiles Involved In the Progression of Pancreatic Ductal Adenocarcinoma | Kung Kai Kuo*, Chao Jen Kuo*, Chiang Yen Chiu, Shih Shin Liang, Shu Wen Chi, Kun Bow Tsai, Chiao Yun Chen, Edward Hsi, Kuang Hung Cheng, Shyh Horng Chiou | Pancreas |
2015-07 | 期刊論文 | Epigenetic Inactivation of TGFbeta1 Target Gene HEYL, a Novel Tumor Suppressor, Involved in the P53 Induced Apoptotic Pathway in Hepatocellular Carcinoma. | Kung-Kai Kuo*, Shu-Fang Jian*, Yi-Jin Li, Shih-Wei Wan, Ching-Chieh Weng, Kuan Te Fang, Deng-Chyang Wu and Kuang- Hung Cheng | Hepatology Research |
2014-07 | 期刊論文 | 17β-Estradiol inhibition of IL-6-Src and Cas and paxillin pathway suppresses human mesenchymal stem cells-mediated gastric cancer cell motility | Liu CJ, Kuo FC, Hu HM, Chen CY, Huang YB, Cheng KH, Yokoyama KK, Wu DC, Hsieh S, Kuo CH. | Translation Research |
2014-07 | 期刊論文 | Effects of Antidepressants on IP-10 Production in LPS-Activated THP-1 Human Monocytes. | Tsai JH, Kuo CH, Yang P, Cheng KH, Wang PW, Chen CC, Hung CH. | Int J Mol Sci. |
2014-05 | 期刊論文 | Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN | Chu TH, Chan HH, Kuo HM, Liu LF, Hu TH, Sun CK, Kung ML, Lin SW, Wang EM, Ma YL, Cheng KH, Lai KH, Wen ZH, Hsu PI, Tai MH. | Oncotarget |
2014-04 | 期刊論文 | SMAD4 Loss Triggers the Phenotypic Changes of Pancreatic Ductal Adenocarcinoma Cells | Yu-Wen Chen, Pi-Jung Hsiao, , Ching-Chieh Weng, Kung-Kai Kuo, Tzu-Lei Kuo, Deng-Chyang Wu, Wen-Chun Hung, Kuang-Hung Cheng | BMC Cancer |
2014-04 | 期刊論文 | Utilization of Liquid Chromatography Mass Spectrometry Analyses to Identify LKB1-APC Interaction in Modulating Wnt/β-Catenin Pathway of Lung Cancer Cells | Shu-Fang Jian, Chang-Chun Hsiao, Shin-Yi Chen, Ching-Chieh Weng, Tzu-Lei Kuo, Deng-Chyang Wu, Wen-Chun Hung and Kuang-Hung Cheng | Molecular Cancer Research |
2014-02 | 期刊論文 | Activation of VCAM-1 and Its Associated Molecule CD44 Leads to Increased Malignant Potential of Breast Cancer Cells | Pei-Chen Wang+, Ching-Chieh Weng+, You-Syuan Hou, Shu-Fang Jian, Kuan-Te Fang , Ming-Feng Hou and Kuang-Hung Cheng | International Journal of Molecular Sciences |
2013-12 | 期刊論文 | Semiconductor Nanomaterials-Based Fluorescence Spectroscopic and Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometric Approaches to Proteome Analysis | Suresh Kumar Kailasa*, Kuang-Hung Cheng* and Hui-Fen Wu | Materials |
2013-07 | 期刊論文 | RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. | Hong KJ, Wu DC, Cheng KH, Chen LT, Hung WC. | J Cell Physiol. |
2013-07 | 期刊論文 | Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. | Su HT, Weng CC, Hsiao PJ, Chen LH, Kuo TL, Chen YW, Kuo KK, Cheng KH | Molecular Cancer Research |
2013-06 | 期刊論文 | Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. | Chiou YS, Sang S, Cheng KH, Ho CT, Wang YJ, Pan MH. | Carcinogenesis |
2013-02 | 期刊論文 | Association between GABA(A) receptor subunit gene cluster and zolpidem-induced complex sleep behaviors in Han Chinese. | Tsai JH, Yang P, Lin HH, Cheng KH, Yang YH, Wu MT, Chen CC. | Sleep |
2012-10 | 期刊論文 | Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. | McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, Daggett J Jr, Cullen K, Kantoff E, Hasselbatt K, Berkowitz J, Muto MG, Berkowitz RS, Aster JC, Matulonis UA, Dinulescu DM. | Proc Natl Acad Sci U S A. |
2012-03 | 期刊論文 | The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. | Chiang-Yen Chiu, Kung-Kai Kuo, Tzu-Lei Kuo, King-The Lee, Kuang-Hung Cheng | Molecular Cancer Research |
2011-11 | 專書 | BMP signaling in primordial germ cell development and maturation. (2011) | H-W. Huang, H-W. Chang, T-L. Kuo, K-H. Cheng (鄭光宏) | Book Title: Bone Morphogenetic Proteins: New Research ; Book chapter, Nova Science Publishers |
2011-10 | 期刊論文 | Human Adipose-Derived Stem Cells: Isolation; Characterization And Current Application In Regeneration Medicine | Kuang-Hung Cheng, Tzu-Lei Kuo, Kung-Kai Kuo, Chang-Chun Hsiao | Genomic Medicine, Biomarkers, and Health Sciences |
2011-01 | 期刊論文 | Smad4 inactivation promotes malignancy and drug resistance of colorectal cancer. | P. Papageorgis, K.H. Cheng, A. W. Lambert1, S.Ozturk1,A. Hamid, J.R. Zhou and S. Thiagalingam*. | Cancer Research |
瀏覽數:
分享